More Uncertainty For Biopharma Players As China Economic Growth Falters

30% Of EU Businesses Report Revenue Decline

China NDA in 2021 sized 1200
China's faltering economy adds new uncertainty for foreign health sector players • Source: Shutterstock

More from China

More from Focus On Asia